Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 557, Issue -, Pages 69-76Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2021.04.008
Keywords
Remifentanil; beta-arrestin 2; Liver regeneration; Cell proliferation
Categories
Funding
- Science and Technology Commission of Shanghai Municipality [20410760500]
- Shanghai Hospital Development Center [SHDC2020CR2055B]
- National Natural Science Foundation of China [81771185, 81800748]
- Shanghai Municipal Key Clinical Specialty [shslczdzk03601]
- Innovation Program of Shanghai Municipal Education Commission [2019-01-07-00-01-E00074]
- Shanghai Engineering Research Center of Peri-operative Organ Support and Function Preservation [20DZ2254200]
Ask authors/readers for more resources
Remifentanil enhances liver regeneration by promoting hepatocyte proliferation rather than anti-inflammatory effects. This effect was confirmed both in vitro and in vivo, and the underlying mechanism may involve the beta-arrestin 2/ERK/cyclin D1 axis.
Remifentanil is a potent, short-acting opioid analgesic drug that can protect tissues from ischemia and reperfusion injury though anti-inflammatory effects. However, the utility of remifentanil in liver regeneration after hepatectomy is not known. Using a 70% hepatectomy mouse model (PHx), we found that preconditioning animals with 4 mu g/kg remifentanil enhanced liver regeneration through supporting hepatocyte proliferation but not through anti-inflammatory effects. These effects were also phenocopied in vitro where 40 mM remifentanil promoted the proliferation of primary mouse hepatocyte cultures. We further identified that remifentanil treatment increased the expression of beta-promote liver regeneration in liver-specific beta-arrestin 2 knockout (CKO) mice subjected to PHx. While remifentanil increased the expression of activated (phosphorylated)-ERK and cyclin D1 in PHx livers, their levels were not signifi-cantly changed in remifentanil-treated CKO mice nor in WT mice pretreated with the ERK inhibitor U0126. Our findings suggest that remifentanil promotes liver regeneration via upregulation of a beta-arrestin 2/ERK/cyclin D1 axis, with implications for improving regeneration process after hepatectomy. (C) 2021 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available